This article is a commentary on:
Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results From an Italian Multicenter Study
Sonia Brio1
Sergio Verd- 1Intensive Care Unit, Department of Paediatrics, Santa Creu I Sant Pau Hospital, Barcelona, Spain
- 2La Vileta Surgery, Paediatric Unit, Balearic Department of Primary Care, Baleares Health Service, Palma de Mallorca, Spain
- 3TERCIT Cell Therapy Department, Balearic Institute of Medical Research (IdISBa), Palma de Mallorca, Spain
- 4Department of Pediatrics, Son Espases University Hospital, Palma de Mallorca, Spain
- 5Intensive Care Unit, Department of Pediatrics, Joan XXIII Hospital, Tarragona, Spain
- 6Intensive Care Unit, Department of Paediatrics, Germans Trias i Pujol Hospital, Barcelona, Spain
A Commentary on:
Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an Italian multicenter study
By Brio S, Verd S, Ramakers J, Sorribes C, Rodríguez-Fanjul X, Díez R. (2022). Front. Pediatr. 10:1067453. doi: 10.3389/fped.2022.1067453
To the Editor,
This insightful paper by Grazzino et al. (1) on paediatric characteristics and risk factors for disease progression of COVID-19 investigates, among other important issues, the possibility that the wide clinical variation observed in this disease may be explained by factors involved in the early stages of life. They point out that ex-prematurity and young age were risk factors for hospital admission, and that viral co-infections predict severe disease. We appreciate the herculean effort undertaken to summarize data from one of the largest European cohorts on paediatric COVID-19. However, we are left with the question of whether a very important aspect of the natural history of SARS-CoV-2 paediatric infection is still missing.
Early after the onset of this pandemic, it was stressed that previous or current optimal nutrition might mitigate the risk and morbidity associated with COVID-19 (2). As hospital-based or primary care paediatricians, and breastfeeding champions, we would like to focus on whether consumption of mother's milk confers benefits against COVID-19 years after lactation is terminated. The influence of breast milk on the development of infectious diseases later in life has been under study for several decades. Early research demonstrated that infants who were breastfed have increased thymus size than those who were formula-fed, and there is a correlation between breastfeeding and CD8 + T cells (3, 4). In addition, breastfeeding is associated with a decreased risk for wheezing (5), otitis (6), H pylori colonization (7), Hib infection (8), appendectomy (9), and tonsillectomy (10) in the medium term. Correspondingly, the odds of young schoolchildren having more than one sick visit per year are significantly associated with the duration and exclusivity of breastfeeding (11).
Human milk feeding triggers lifetime immune-protective responses by the host through various mechanisms. Among others, mucosal maturation, immune modulation, microbiota shaping, or balance between pro-inflammatory and antioxidant status contribute to the antiviral activity of human milk (12).
A study on the UK Biobank population cohort aimed to identify associations between early life factors, including breastfeeding, and the risk of COVID-19 infection and hospitalization. The longitudinal UK Biobank cohort includes more than half a million participants aged 37–73 years old when recruited in 2006–2010. Early-life variables were self-reported, and respondents were categorized as breastfed if they confirmed that they were breastfed when they were babies. Of all eligible respondents, 43,428 had been COVID-19 tested, 7,733 had tested positive and 2,494 were hospitalized due to COVID-19. A multivariate logistic model showed that respondents who were breastfed had 12% lower odds of contracting COVID-19 in the first peak just as much as in the second peak of this pandemic. Breastfeeding was negatively associated with hospitalization only in the first peak (13).
On a much smaller scale, our practices in the community or hospital settings embraced the opportunity to perform targeted surveys to check whether the previous breastfeeding prevents SARS-CoV-2 colonization or the Multisystem Inflammatory Syndrome in Children associated with COVID (MIS-C). For this purpose, during the second peak of the COVID-19 pandemic, we analyzed the effect of any breastfeeding on the risk of testing positive for SARS-CoV-2 among 691 Majorcan children (mean age = 67.8 months) attending community or hospital emergency services. We found that approximately 1 in 60 ever-breastfed children had tested positive for SARS-CoV-2, at odds with 1 in 25 never breastfed children (OR, 2.48; P = 0.036) (14). Hence, it was proven that initially breastfed children in our area remained at lower risk of COVID-19 during August–December 2020 than exclusively previously formula-fed children. However, a difficulty with breastfeeding studies is being able to disentangle the underlying pathways that link breastfeeding to social class. Spanish as well as global previous research shows that mothers with higher socio-economic status or higher level of education breastfeed for longer periods (15–17). Regarding MIS-C, we have included in a clinical case series all children with this diagnosis, admitted to three University hospitals in Catalonia (North–East Spain) during 2020 and 2021. A brief face-to-face questionnaire was used to collect quality data recalled about lactation. We found that only nine out of sixteen children (56%) with MIS-C from our case series had been breastfed at birth (18). The 2017 Spanish Health Survey has reported that eight out of ten Spanish children (80%) are breastfed at hospital discharge (19). According to national standards, Spanish children have about a one-third-better rate of breastfeeding initiation than children with MIS-C in our sample. Hence, the potential protective role of breastfeeding against MIS-C cannot be discarded. But we cannot fail to underline that there are a number of well-known factors that can worsen the clinical picture of COVID-19 (20, 21). In this sense, we must finally admit that the small size of our case series has not allowed us to identify further clinical or demographic characteristics, such as ethnicity, age, overweight, gender, disability, or respiratory pathology, that explain the wide variability of paediatric COVID-19.
Severe COVID-19 is associated with uncontrolled inflammation. Children who were ever breastfed have lower levels of biomarkers that are increased during the cytokine burst (i.e., ferritin, serum monocyte chemoattractant protein-1, or uric acid) than their formula-fed peers (6–9). For this reason, patients who have been breastfed may be in the best position to restore the oxidative balance when they are infected with this virus. In addition, there are likely to be lower rates of prematurity and viral co-infection among children who were breastfed, both risk factors for COVID-19 according to Grazzino et al. In conclusion, there is still a need for a systematic overview of not only recent but also early life characteristics that may influence COVID-19, with emphasis on infant feeding. This would allow researchers and physicians to better understand inequalities in the severity of the disease.
Author contributions
CS and JR and contributed to the conception of the work and to filling-in the registry forms on patient information. XR-F and was responsible for data entry and original drafting of the manuscript. SB, SV and RD contributed to the critical revision of the intellectual content. All authors contributed to the article and approved the submitted version.
Acknowledgments
The authors are grateful to the staff of Bibliosalut, the Balearic Library of Health Sciences.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Garazzino S, Lo Vecchio A, Pierantoni L, Calò Carducci FI, Marchetti F, Meini A, et al. Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an Italian multicenter study. Front Pediatr. (2021) 9:649358. doi: 10.3389/fped.2021.649358
2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. (2020) 395:507–13. doi: 10.1016/S0140-6736(20)30211-7
3. Hasselbalch H, Jeppesen DL, Engelmann MD, Michaelsen KF, Nielsen MB. Decreased thymus size in formula-fed infants compared with breastfed infants. Acta Paediatr. (1996) 85:1029–32. doi: 10.1111/j.1651-2227.1996.tb14211.x
4. Jeppesen DL, Hasselbalch H, Lisse IM, Ersbøll AK, Engelmann MD. T-lymphocyte subsets, thymic size and breastfeeding in infancy. Pediatr Allergy Immunol. (2004) 15:127–32. doi: 10.1111/j.1399-3038.2004.00032.x
5. Porro E, Indinnimeo L, Antognoni G, Midulla F, Criscione S. Early wheezing and breast feeding. J Asthma. (1993) 30:23–8. doi: 10.3109/02770909309066376
6. Saarinen UM. Prolonged breast feeding as prophylaxis for recurrent otitis media. Acta Paediatr Scand. (1982) 71:567–71. doi: 10.1111/j.1651-2227.1982.tb09476.x
7. Pearce MS, Thomas JE, Campbell DI, Parker L. Does increased duration of exclusive breastfeeding protect against Helicobacter pylori infection? The Newcastle thousand families cohort study at age 49-51 years. J Pediatr Gastroenterol Nutr. (2005) 41:617–20. doi: 10.1097/01.mpg.0000179857.76592.05
8. Silfverdal SA, Bodin L, Hugosson S, Garpenholt O, Werner B, Esbjörner E, et al. Protective effect of breastfeeding on invasive Haemophilus influenzae infection: a case-control study in Swedish preschool children. Int J Epidemiol. (1997) 26:443–50. doi: 10.1093/ije/26.2.443
9. Pisacane A, de Luca U, Impagliazzo N, Russo M, De Caprio C, Caracciolo G. Breast feeding and acute appendicitis. Br Med J. (1995) 310:836–7. doi: 10.1136/bmj.310.6983.836
10. Pisacane A, Impagliazzo N, De Caprio C, Criscuolo L, Inglese A, Pereira de Silva MC. Breast feeding and tonsillectomy. Br Med J. (1996) 312:746–7. doi: 10.1136/bmj.312.7033.746
11. Li R, Dee D, Li CM, Hoffman HJ, Grummer-Strawn LM. Breastfeeding and risk of infections at 6 years. Pediatrics. (2014) 134(1):S13–20. doi: 10.1542/peds.2014-0646D
12. Oddy WH. Breastfeeding protects against illness and infection in infants and children: a review of the evidence. Breastfeed Rev. (2001) 9:11–8.11550600
13. Didikoglu A, Maharani A, Pendleton N, Canal MM, Payton A. Early life factors and COVID-19 infection in England: a prospective analysis of UK biobank participants. Early Hum Dev. (2021) 155:105326. doi: 10.1016/j.earlhumdev.2021.105326
14. Verd S, Ramakers J, Vinuela I, Martin-Delgado MI, Prohens A, Díez R. Does breastfeeding protect children from COVID-19? An observational study from pediatric services in majorca, Spain. Int Breastfeed J. (2021) 16:83. doi: 10.1186/s13006-021-00430-z
15. Der G, Batty GD, Deary IJ. Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. Br Med J. (2006) 333:945. doi: 10.1136/bmj.38978.699583.55
16. Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep). (2007) 153:1–186.
17. Julvez J, Guxens M, Carsin AE, Forns J, Mendez M, Turner MC, et al. A cohort study on full breastfeeding and child neuropsychological development: the role of maternal social, psychological, and nutritional factors. Dev Med Child Neurol. (2014) 56:148–56. doi: 10.1111/dmcn.12282
18. Rodríguez-Fanjul X, Verd S, Brio S. Can breastfeeding protect from multi-system inflammatory syndrome in children (MIS-C)? A Preliminary Study. Children (Basel). (2022) 9:1160. doi: 10.3390/children9081160
19. Ministerio de Sanidad y Consumo. Encuesta Nacional de Salud España. (2017). Available at: https://www.sanidad.gob.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2017/ENSE17_pres_web.pdf (Accessed October 7, 2022).
20. Rhedin S, Lundholm C, Horne A, Smew AI, Osvald EC, Haddadi A, et al. Risk factors for multisystem inflammatory syndrome in children - A population-based cohort study of over 2 million children. Lancet Reg Health Eur. (2022) 19:100443. doi: 10.1016/j.lanepe.2022.100443
21. Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. (2021) 5:323–31. doi: 10.1016/S2352-4642(21)00050-X
Keywords: neonate, breastfeeding, human milk, COVID-19, kawasaki disease
Citation: Brio S, Verd S, Ramakers J, Sorribes C, Rodríguez-Fanjul X and Díez R (2022) Commentary: Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: Results from an Italian multicenter study. Front. Pediatr. 10:1067453. doi: 10.3389/fped.2022.1067453
Received: 11 October 2022; Accepted: 24 October 2022;
Published: 9 December 2022.
Edited by:
Anna B. Nilsson, Karolinska Institutet (KI), SwedenReviewed by:
Samuel Arthur Rhedin, Karolinska Institutet (KI), Sweden© 2022 Brio, Verd, Ramakers, Sorribes, Rodríguez-Fanjul and Díez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sergio Verd ZHJzdmVyZEBnbWFpbC5jb20=
Specialty Section: This article was submitted to Pediatric Immunology, a section of the journal Frontiers in Pediatrics